Recruiting
Type 1 diabetes mellitus+1
RecruitingStudy of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin
InvestigationalNo placebo
Study of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin
InvestigationalNo placebo
- Disease:Type 1 diabetes mellitusDiabetes mellitus
- Substances:IMMUNOSTEM
Countries:
Italy
Italy- Participants:18–64 years
- Substances:IMMUNOSTEM